Becker's Healthcare January 31, 2025
Paige Twenter

While the American Society of Health-System Pharmacists largely supports CMS’ proposed policy revisions for Medicare Part D, Medicare Advantage and the program of all-inclusive care for the elderly, or PACE, the ASHP is asking the agency to “change course” on a proposed rule.

In a Jan. 27 letter, the ASHP, which represents 60,000 U.S. pharmacists, pharmacy technicians and student pharmacists, shared concerns with CMS’ proposed framework for how it will implement negotiated drug prices.

“Although we support the underlying goals of the IRA’s [Inflation Reduction Act] price negotiations, the proposed framework threatens patients by undermining the financial stability of hospitals, pharmacies, and other community providers,” the letter said.

In 2022, CMS gained the authority to negotiate with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Physicians rally behind Medicare payment bill
What they’re saying about the Medicare Patient Access and Practice Stabilization Act 2025
Supplier Concentration In Medicaid Managed Care: A Cause For Concern
States ranked by average ACA claim denial rates
Trade group urges pause on sweeping Medicare Advantage proposed rule

Share This Article